Abilify Maintena

Abilify Maintena is an extended-release injectable formulation of aripiprazole, used for long-term management of certain mental health conditions. This medication is designed for intramuscular use and is manufactured by Otsuka Pharmaceutical Netherlands B.V.

Abilify Maintena is primarily used for the maintenance treatment of schizophrenia in adults. It is designed to provide a steady release of aripiprazole over an extended period, which may help manage symptoms over time. This medication is administered via intramuscular injection and is intended for long-term use under medical supervision.

Common effects of Abilify Maintena may include injection site reactions, such as pain, swelling, or redness. Some individuals may also experience restlessness, insomnia, or weight changes. These effects can vary and are not exhaustive; always consult a healthcare provider for personalized advice.

Abilify Maintena should be handled with care and administered by a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions before starting this medication. Regular monitoring may be required to ensure safety and effectiveness.

Abilify Maintena may interact with other medications, including those that affect the central nervous system or are metabolized by certain liver enzymes. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances may also affect how this medication works.